Eli Lilly CEO John Lechleiter did his best to balance bad news with good after the company posted disappointing earnings Tuesday. But Lilly's still counting on old blockbusters to prop up sales, and one of those mainstays slipped big-time.
Eli Lilly & Co. CEO John Lechleiter is moving on. The outspoken CEO--who presided over a tumultuous period at Lilly, always promising a turnaround--will retire as of year’s end, and SVP David Ricks will take the reins.
Eli Lilly CEOJohn Lechleiterhas suffered some tough years this decade, as top sellers such asZyprexawent off patent and a series of R&D setbacks put a crimp in the company's plans to fill those gaps. But 2015 turned out better than expected--and it shows in Lechleiter's pay.